The PC-COVID-19 Group revealed that, after completing the pilot phase for this treatment -the first and only one so far authorized by the Colombia National Food and Drug Surveillance Institute (INVIMA)- the randomized controlled trial in which 90 patients will be studied in Colombia has started.